[{"Assets_0_Q3_USD":216957000.0,"CommonStockSharesOutstanding_0_Q3_shares":45842966.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-63991000.0,"NetIncomeLoss_1_Q3_USD":-22352000.0,"NetIncomeLoss_3_Q3_USD":-68112000.0,"StockholdersEquity_0_Q3_USD":177227000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":45787137.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":45253176.0,"Ticker":"RCUS","CIK":"1724521","name":"ARCUS BIOSCIENCES, INC.","OfficialName":"Arcus Biosciences Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2226368293.0","Country":"nan","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20191105"}]